SavedAdd your journal

Journals / Zeynep Kamil Tıp Bülteni / 2026 / Cilt: 49 Sayı: 1

Romatizmal Kalp Hastalıklarında Ortalama Trombosit Hacmi ve Trombosit Dağılım Genişliği

Elif Çelik(özel magnet hastanesi,pedyatri kliniği ,kayseri)
Serkan Fazlı Çelik(kayseri sağlık bilimleri üniversitesi)0000-0003-1595-802X
Pages
9–11
Publication Date
2018-03-05
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When MPV / PDW ratio was examined, it was found to be significantly lower in the RHD group (0,61 (0,55-0,71) and 0,87 (0,79-0,93), p: 0,001).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Rheumatoid heart disease (RHD) is an important and preventable cause of cardiovascular disease in developing countries.
📊
Key Findings & Data:Material and Methods: This study was carried out in Kayseri Health Sciences University, Department of Pediatric Cardiology, with 135 children with RHD who were retrospectively observed between February 2000 and February 2017 for seven years and 40 healthy children with similar age and sex.
💡
Conclusion & Impact:When MPV / PDW ratio was examined, it was found to be significantly lower in the RHD group (0,61 (0,55-0,71) and 0,87 (0,79-0,93), p: 0,001).
🔬Design:Araştırma Makalesi
📍Scope:2000 Verileri
⚙️Variables:ortalama trombosit hacmi · trombosit dağılım genişliği · romatizmal kalp hastalığı

Abstract

Objective: Rheumatoid heart disease (RHD) is an important and preventable cause of cardiovascular disease in developing countries. The aim of this study was to investigate the mean platelet volume (MPV) and platelet distribution width (PDW) in RHD. Material and Methods: This study was carried out in Kayseri Health Sciences University, Department of Pediatric Cardiology, with 135 children with RHD who were retrospectively observed between February 2000 and February 2017 for seven years and 40 healthy children with similar age and sex. Results: The mean age of the 135 patients enrolled in the study was 12,43 ± 3,11 years, 70 were males (51,8%) and 65 were females (48,2%). The mean age of the control group was 12,96 ± 2,55 years, 21,21 male (52,5%) and 19 female (47,5%). MPV values of the patients were significantly lower in the RHD group (9,43 ± 1,31 and 10,21 ± 1,25, p: 0,003). Conversely, the PDW levels were significantly higher in the RHD group (15,70 (15,40-16,00) and 12,25 (10,40-14,30), p: 0,001). When MPV / PDW ratio was examined, it was found to be significantly lower in the RHD group (0,61 (0,55-0,71) and 0,87 (0,79-0,93), p: 0,001). Conclusion: MPV values were lower and PDW values were higher when compared to controls in RHD process.

Özet

Amaç: Romatizmal kalp hastalığı (RKH), kardiyovasküler hastalıkların gelişmekte olan ülkelerde endemik seyreden önemli ve önlenebilir bir nedenidir. Bu çalışmanın amacı RKH’da ortalama trombosit hacmini (MPV) ve trombosit dağılım genişliğini (PDW) araştırmaktır. Materyal ve Metod: Bu çalışma Kayseri Sağlık Bilimleri Üniversitesi Çocuk Kardiyoloji Bölümü’nde, Şubat 2000-Şubat 2017 tarihleri arasında retrospektif olarak yedi yıllık süreçte izlenen 135 RKH’li çocuk hasta ile yaş ve cinsiyetleri benzer 40 sağlıklı çocuğu içermektedir. Bulgular: Çalışmaya alınan 135 olgunun yaş ortalaması 12,43±3,11 yıl, 70’i erkek (%51,8), 65’i kız (%48,2) idi. Kontrol grubunun yaşları ortalaması 12,96±2,55 yıl, 21’i erkek (%52,5)),19‘u kız (%47,5) olmak üzere 40 idi. Hastaların MPV değerleri RKH’lı grupta anlamlı derecede düşüktü (9,43±1,31 ve 10,21±1,25; p:0,003). Tersine PDW seviyeleri RKH’lı grupta anlamlı derecede yüksekti (15,70 (15,40-16,00) ve 12,25(10,40- 14,30); p: 0,001). MPV/PDW oranı RKH’lı grupta anlamlı derecede düşük saptandı (0,61(0,55-0,71) ve 0,87(0,79 0,93); p: 0,001). Sonuç: RKH sürecinde kontrol grubuyla kıyaslandığında MPV düşüklüğü ve PDW yüksekliği mevcutttur.

🔖

Cite This Article

Çelik, E., Çelik, S. F. (2018). Romatizmal Kalp Hastalıklarında Ortalama Trombosit Hacmi ve Trombosit Dağılım Genişliği. Zeynep Kamil Tıp Bülteni, Cilt: 49 Sayı: 1, 9–11. https://doi.org/10.16948/zktipb.306583

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Reményi B., Wilson N., Steer A., Ferreira B., Kado J., Kumar K., et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nature Reviews Cardiology. 2012;9(5):297–309.
  2. Rémond M., Atkinson D., White A., Brown A., Carapetis J., Remenyi B., et al. Are minor echocardiographic changes associated with an increased risk of acute rheumatic fever or progression to rheumatic heart disease? International Journal of Cardiology. 2015;198:117–122.
  3. Bath PM, Butterworth RJ (1996) Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7(2):157–161
  4. Pitchford SC, Page CP (2006) Platelet activation in asthma: integral to the inflammatory response. Clin Exp Allergy 36(4):399–401
  5. Herve P, Humbert M, Sitbon O, Parent F, Nunes H, Legal C et al. (2001) Pathobiology of pulmonary hypertension: the role of platelets and thrombosis. Clin Chest Med 22(3):451–458
  6. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD (2011) Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17(1):47–58
  7. Sert A, Aypar E, Odabas D (2012) Mean platelet volume in acute rheumatic fever. Platelets.
  8. Rahmi Ozdemir, Cem Karadeniz, Onder Doksoz et al. Are Mean Platelet Volume and Platelet Distribution Width Useful Parameters in Children With Acute Rheumatic Carditis. Pediatr Cardiol DOI 10.1007/s00246-013-0738-9
  9. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation? Curr Pharm Des 2011;17:47–58.
  10. Kim DA, Kim TY. Controversies over the interpretation of changes of mean platelet volume in rheumatoid arthritis. Platelets 2011;22:77–78.
  11. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA. Mean platelet volume: A useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001;96:776–781.
  12. Gasparyan AY, Stavropoulos-Kalinoglou A, Toms TE, Douglas KM, Kitas GD. Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets 2010;9:45–50.
  13. Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, Kiraz S, Ertenli I, Calguneri M. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008;75:291–294
  14. Clarke D, Johnson PW, Banks RE, Storr M, Kinsey SE, Johnson R, Morgan G, Gordon MY, Illingworth JM, Perren TJ, et al. Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood. Cytokine 1996;8:717–723.
  15. Settin A, Abdel-Hady H, El-baz R, Saber I. Gene polymorphisms of TNF-α ( 308), IL-10 ( 1082), and IL-1Ra (VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol 2007;28:363–371.
  16. Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A,Kitas GD. Mean platelet volume in patients with rheumatoid arthritis: The effect of anti-TNF-α therapy. Rheumatol Int 2010;30:1125–1129.
  17. Yegin O, Coskun M, Ertug H (1997) Cytokines in acute rheumatic fever. Eur J Pediatr 156(1):25–29
  18. Hafez M, El-Morsy Z, El-Shennawy F, Hawas S, Sheishaa A, AlMarsafawy H et al (2001) Cytokine gene expression in rheumatic fever. Egypt J Immunol 8:61–76